Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study.
- DOI
- 10.1016/j.eprac.2026.06.004
- Published
- 2026 Jun 19
- Container
- Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eprac.2026.06.004,
title = {Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study.},
author = {Khalil I and Sarker P and Hossain MI and Chowdhury A and Anwar Khalid A and Saha A and Chowdhury J and Akter MM and Promi SA and Sayed MA and Rahman MT and Kamrul-Hasan ABM},
year = {2026},
journal = {Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
doi = {10.1016/j.eprac.2026.06.004},
url = {https://doi.org/10.1016/j.eprac.2026.06.004}
}RIS
TY - JOUR TI - Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study. AU - Khalil I AU - Sarker P AU - Hossain MI AU - Chowdhury A AU - Anwar Khalid A AU - Saha A AU - Chowdhury J AU - Akter MM AU - Promi SA AU - Sayed MA AU - Rahman MT AU - Kamrul-Hasan ABM PY - 2026 JO - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists DO - 10.1016/j.eprac.2026.06.004 UR - https://doi.org/10.1016/j.eprac.2026.06.004 ER -
APA
I, K., P, S., MI, H., A, C., A, A. K., A, S., J, C., MM, A., SA, P., MA, S., MT, R., & ABM, K. (2026). Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study.. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. https://doi.org/10.1016/j.eprac.2026.06.004
Source records
- pubmed · retrieved 2026-09-25T22:45:10.376Z
- europe-pmc · retrieved 2026-09-25T22:45:10.381Z